Pharmacogenetics: From Bench to Byte— An Update of Guidelines von Swen, JJ, Nijenhuis, M, Boer, A, Grandia, L, Maitland‐van der Zee, AH, Mulder, H, Rongen, GAPJM, Schaik, RHN, Schalekamp, T, Touw, DJ, Weide, J, Wilffert, B, Deneer, VHM, Guchelaar, H‐J

Volltext

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group von Bank, PCD, Caudle, KE, Swen, JJ, Gammal, RS, Whirl‐Carrillo, M, Klein, TE, Relling, MV, Guchelaar, H‐J

Volltext

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis von Wessels, J. A. M., Huizinga, T. W. J., Guchelaar, H.-J.

Volltext

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands von Bank, P C D, Swen, J J, Guchelaar, H J

Volltext

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials von Slingerland, M., Cerella, C., Guchelaar, H. J., Diederich, M., Gelderblom, H.

Volltext

The role of pharmacogenetics in capecitabine efficacy and toxicity von Lam, S.W, Guchelaar, H.J, Boven, E

Volltext

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype von Broekman, M. M. T. J., Coenen, M. J. H., Wanten, G. J., van Marrewijk, C. J., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Guchelaar, H.‐J., Scheffer, H., Derijks, L. J. J., Wong, D. R., Jong, D. J.

Volltext

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions von Vermes, A., Guchelaar, H.-J., Dankert, J.

Volltext

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects von Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., Maartense, E., Smorenburg, C. H., Putter, H., Dieudonné, A. S., Neven, P., Van de Velde, C. J. H., Nortier, J. W. R., Guchelaar, H.-J.

Volltext

Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency von van Staveren, M C, Jan Guchelaar, H, van Kuilenburg, A B P, Gelderblom, H, Maring, J G

Volltext

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium von van der Wouden, CH, Cambon‐Thomsen, A, Cecchin, E, Cheung, KC, Dávila‐Fajardo, CL, Deneer, VH, Dolžan, V, Ingelman‐Sundberg, M, Jönsson, S, Karlsson, MO, Kriek, M, Mitropoulou, C, Patrinos, GP, Pirmohamed, M, Samwald, M, Schaeffeler, E, Schwab, M, Steinberger, D, Stingl, J, Sunder‐Plassmann, G, Toffoli, G, Turner, RM, van Rhenen, MH, Swen, JJ, Guchelaar, H‐J

Volltext

Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review von Frederiks, C.N, Lam, S.W, Guchelaar, H.J, Boven, E

Volltext

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy von Kweekel, D.M., Gelderblom, H., Guchelaar, H.-J.

Volltext

Recommendations on management of EGFR inhibitor-induced skin toxicity: A systematic review von Baas, J.M, Krens, L.L, Guchelaar, H.-J, Ouwerkerk, J, Jong, F.A de, Lavrijsen, A.P.M, Gelderblom, H

Volltext

Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer von Souwer, E. T. D., Sanchez-Spitman, A., Moes, D. J. A. R., Gelderblom, H., Swen, J. J., Portielje, J. E. A., Guchelaar, H. J., van Gelder, T.

Volltext

Pharmacogenetics: From Bench to Byte von Swen, JJ, Wilting, I, Goede, AL, Grandia, L, Mulder, H, Touw, DJ, Boer, A, Conemans, JMH, Egberts, TCG, Klungel, OH, Koopmans, R, Weide, J, Wilffert, B, Guchelaar, H‐J, Deneer, VHM

Volltext

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU... von Knikman, de Vries, Niels, Rosing, Cats, Guchelaar, H.-J., Beijnen

Volltext

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial von Arbouw, M E L, Movig, K L L, Koopmann, M, Poels, P J E, Guchelaar, H-J, Egberts, T C G, Neef, C, van Vugt, J P P

Volltext

The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs von van Leeuwen, N., Swen, J. J., Guchelaar, H.-J., ’t Hart, L. M.

Volltext

3D printed furosemide and sildenafil tablets: Innovative production and quality control von Lafeber, I., Tichem, J.M., Ouwerkerk, N., van Unen, A.D., van Uitert, J.J.D., Bijleveld-Olierook, H.C.M., Kweekel, D.M., Zaal, W.M., Le Brun, P.P.H., Guchelaar, H.J., Schimmel, K.J.M.

Volltext